Healthcare · Tue 10 Nov

AIAI-generated summary iORGANBIO has received a strategic investment from Mitsui Chemicals through the 321Catalyst fund and is collaborating to combine its closed-loop artificial intelligence platform with high-oxygen-permeability cell culture plates. iORGANBIO states that its CellForge platform belongs to a category of technology called Physical AI, combining artificial intelligence prediction with robotic execution in a continuous feedback loop.

Physical AI AI for Science Healthcare

AIAI-generated summary Charta Health announced on November 10, 2026, that it secured a $55 million Series B financing round led by Insight Partners to expand its artificial intelligence chart-review technology. The company states that its software applies large language models to unstructured medical material to review charts against coding guidelines before claims are billed.

Startups Funding Enterprise AI Healthcare

AIAI-generated summary The Ohio State University and Microsoft Corp. announced a five-year strategic partnership to integrate Microsoft AI and cloud technologies into clinical care, education, and research at the Ohio State University Wexner Medical Center. Microsoft says the collaboration will help clinicians spend more time with patients, support care teams, and build a trusted foundation for artificial intelligence and cloud-driven innovation.

Microsoft Partnerships Enterprise AI Healthcare

AIAI-generated summary Oura Inc. agreed to acquire artificial intelligence and on-demand doctor service Counsel Health Inc. for $625 million. The company also stated that its revenue jumped 153% during the fiscal fourth quarter that ended Sept. 30.

Acquisitions Healthcare

AIAI-generated summary Alterra Labs announced a $12.5 million seed round to build simulated medical environments for testing and training AI models. Founder and CEO Akash Kapoor stated that current models often struggle with clinical judgment and knowing when not to act.

Startups Funding Healthcare

AIAI-generated summary GoodRx Holdings Inc shares rose after the company announced a partnership with Google Cloud to integrate its prescription pricing into the Gemini for healthcare platform. GoodRx stated that the integration allows healthcare enterprises to access pricing data and compare pharmacy costs through AI-powered workflows.

Google Gemini Partnerships Enterprise AI Healthcare

AIAI-generated summary HCLTech is participating as a launch partner for Google Cloud's Gemini for healthcare to deliver industry-specific agentic AI solutions. HCLTech says its solutions help providers and payers accelerate adoption and address complex industry challenges.

Google Gemini Partnerships Enterprise AI Healthcare

AIAI-generated summary Google Cloud has announced the launch of Gemini for healthcare, which is a new agentic AI solution designed to connect clinical and administrative data. Google Cloud says the platform helps ease operational pressures and administrative burnout while supporting HIPAA compliance.

Google Gemini Workflow Automation Enterprise AI Healthcare

AIAI-generated summary UiPath announced it is a launch partner for Google Cloud’s Gemini for healthcare, enabling organizations to connect Gemini to automations and agents on the UiPath Platform. UiPath says the integration helps healthcare organizations automate complex enterprise workflows with governance, permissions, and audit controls.

Google Gemini Workflow Automation Partnerships Enterprise AI

AIAI-generated summary Elomia Health has acquired Earkick to expand its artificial intelligence mental wellbeing platform and API offerings. The deal also provides access to artificial intelligence models and the Mia21 memory engine originally developed by the Earkick team.

Acquisitions Enterprise AI Healthcare

AIAI-generated summary Researchers are using artificial intelligence to understand cancer at a detailed level and develop personalized treatments based on a patient's unique genetic tumor makeup. In a Phase 3 trial, an experimental personalized melanoma vaccine developed by Moderna and Merck combined with Keytruda reduced recurrence or death risk by 42% compared with Keytruda alone.

AI for Science Healthcare